Study wrapper · #376
Effect of Ala-Glu-Asp-Gly peptide on life span and development of spontaneous tumors in female rats exposed to different illumination regimes.
Editor's note
This is one of the more substantive rodent studies in epitalon's file: a lifespan-and-tumour experiment in female rats under standard, natural (northern-Russian), and constant illumination. Researchers reported that disruptive lighting shortened mean lifespan and accelerated spontaneous tumour development, and that low-dose epithalon (0.1 microgram, 5 days/week from 4 months of age) did not change lifespan under a standard light/dark schedule but was associated with a modestly prolonged maximum lifespan under natural and constant light (about 95 and 24 days), and with inhibited spontaneous tumour development specifically under natural light. The effects are real but conditional — they appear only under light stress, are modest in magnitude, and the tumour effect was selective to one lighting condition. This is a preclinical in-vivo study from the originating lineage; rodent lifespan and carcinogenesis data translate poorly to humans and remain largely un-replicated externally. Human data are needed before any conclusions about longevity or cancer risk.
Plain-language abstract
In this study, female rats were kept under three lighting conditions — a normal day/night cycle, the natural changing light of north-western Russia, and constant light — to see how the peptide epithalon (epitalon) affected how long they lived and how quickly spontaneous tumours developed. Disruptive lighting (constant or natural) shortened the rats' average lifespan and sped up tumour development compared with the normal light schedule. A small dose of epithalon, given five days a week from four months of age, did not change lifespan in rats on the normal light schedule. But in rats under natural or constant light, it was linked to a modest increase in the longest lifespans (about 95 and 24 extra days) and, under natural light only, to slower development of spontaneous tumours. The benefits appeared only when lighting was disruptive and were modest. This was an animal study; the findings do not directly apply to people, and no human side-effect data were reported.